Загрузка...
Effective control of sickle cell disease with hydroxyurea therapy
OBJECTIVE: Hemoglobin F augmentation is another approach to treat sickle cell disease (SCD). This study evaluates the efficacy and impact of Hydroxyurea (HU) on fetal hemoglobin (HbF) and other hematological parameters, which result in decreasing the painful crisis and lower hospital admissions. MAT...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2885637/ https://ncbi.nlm.nih.gov/pubmed/20606834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.62409 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|